Literature DB >> 33048180

Symptomatic and anatomic improvement of pelvic organ prolapse in vaginal pessary users.

Lanuza Celes Mendes1, Leonardo Robson Pinheiro Sobreira Bezerra2, Andreisa Paiva Monteiro Bilhar2, José Ananias Vasconcelos Neto2, Camila Teixeira Moreira Vasconcelos2, Dayana Maia Saboia2, Sara Arcanjo Lino Karbage2.   

Abstract

INTRODUCTION AND HYPOTHESIS: The vaginal pessary is a conservative method for treating pelvic organ prolapse (POP). It is able to reduce symptoms with minimal complications, improving quality of life (QOL). This study's hypothesis was that the use of pessaries decreases quantitative measures and improves women's QOL. We aimed to evaluate the effects of the use of a ring pessary on the quantitative measurements of POP by the Pelvic Organ Prolapse Quantification (POP-Q) and on QOL.
METHODS: Prospective cohort study divided in two stages. In stage I POP-Q and QOL were assessed prior to the use of the ring pessary and in stage II after its use for at least 4 months with pessary removal 72 h before clinical evaluation. Wilcoxon tests were performed for necessary comparisons and Spearman's tests for calculating correlations.
RESULTS: One hundred thirty-six women were evaluated, of which 50 were included. There was a decrease in POP in at least one of the vaginal compartments in the women included. When assessing individual measures (Ba, Bp and C), reductions in all measures were observed. There was also an improvement in the general and specific quality of life of women.
CONCLUSION: The ring pessary proved to be a good therapeutic option, with a reduction in POP-Q measurements and/or absence of POP progression in the short term and an improvement in women's QOL.

Entities:  

Keywords:  Conservative treatment; Pelvic organs prolapse; Pessary; Vaginal prolapse

Mesh:

Year:  2020        PMID: 33048180     DOI: 10.1007/s00192-020-04540-w

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  7 in total

1.  Impact on quality of life after ring pessary use for pelvic organ prolapse.

Authors:  Tarinee Manchana; Suvit Bunyavejchevin
Journal:  Int Urogynecol J       Date:  2012-01-06       Impact factor: 2.894

2.  The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction.

Authors:  R C Bump; A Mattiasson; K Bø; L P Brubaker; J O DeLancey; P Klarskov; B L Shull; A R Smith
Journal:  Am J Obstet Gynecol       Date:  1996-07       Impact factor: 8.661

3.  Quality of life and vaginal symptoms of postmenopausal women using pessary for pelvic organ prolapse: a prospective study.

Authors:  Suelene C Albuquerque Coelho; Marcos Marangoni-Junior; Luiz Gustavo Oliveira Brito; Edilson Benedito de Castro; Cássia Raquel Teatin Juliato
Journal:  Rev Assoc Med Bras (1992)       Date:  2018-12       Impact factor: 1.209

4.  [Clinical study on silicone pessary in the treatment of pelvic organ prolapse].

Authors:  Jun-fang Yang; Jin-song Han; Fu-li Zhu; Yi-ting Wang; Ying Yao; Jie Qiao
Journal:  Zhonghua Fu Chan Ke Za Zhi       Date:  2012-07

5.  Trends in inpatient prolapse procedures in the United States, 1979-2006.

Authors:  Keisha A Jones; Jonathan P Shepherd; Sallie S Oliphant; Li Wang; Clareann H Bunker; Jerry L Lowder
Journal:  Am J Obstet Gynecol       Date:  2010-03-11       Impact factor: 8.661

6.  Effect of pessary use on genital hiatus measurements in women with pelvic organ prolapse.

Authors:  Keisha Jones; Linda Yang; Jerry L Lowder; Leslie Meyn; Rennique Ellison; Halina M Zyczynski; Pamela Moalli; Ted Lee
Journal:  Obstet Gynecol       Date:  2008-09       Impact factor: 7.661

Review 7.  Pessary treatment for pelvic organ prolapse and health-related quality of life: a review.

Authors:  Babet H C Lamers; Bart M W Broekman; Alfredo L Milani
Journal:  Int Urogynecol J       Date:  2011-04-07       Impact factor: 2.894

  7 in total
  1 in total

1.  Predictors for long-term adherence to vaginal pessary in pelvic organ prolapse: a prospective study.

Authors:  Danielle I Niigaki; Rebecca S P Silva; Maria Augusta Tezelli Bortolini; Fátima F Fitz; Rodrigo A Castro
Journal:  Int Urogynecol J       Date:  2022-03-14       Impact factor: 1.932

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.